Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

National Institutes of Health

This is the reissuance of Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards ( NOT-OD-20-055 ). The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diverse talent in the biomedical research workforce. This program supports “at-risk” investigators as identified in the NIH Next Generation Researchers Initiative (see https://grants.nih.gov/ngri.htm ).

This retention program seeks to maintain the productivity of current first-time recipients of eligible independent NIH research project grant awards who are dealing with a critical life event(s), such that they can remain competitive for the first renewal of their award or for a second research project grant award. For retention supplements to support the transition from K award to independence, see the companion NOSI ( NOT-OD-23-031 ).

Investigators, especially women, leave science at critical transition stages or branching points in their career which for the NIH-supported scientific workforce include transitions from post-doctoral training to faculty positions ( Heggeness et al. , 2016 Aug; 91(8):1164-72, Acad Med ; Nikaj et al., 2019, the FASEB Journal ) and prior to obtaining their first R01 renewal ( Hechtman et al. , 2018: 115(31)7943-7948, PNAS ). The rate of R01/R01-equivalent renewals has potential impact on the longevity of an investigator’s research career ( Pohlhaus et al. , 2011 Jun; 86(6):759-67, Acad Med ) and there remains a gender disparity in NIH funding that should be addressed. These vulnerable career stages often parallel critical life events that commonly contribute to faculty attrition. Data from NSF demonstrate that among biomedical scientists and engineers, women are far more likely than men to cite family responsibilities as a reason for being unemployed or leaving the workforce. ( NCSES Report – Employment , especially figure 30).

Pregnancy and childbirth in particular, appear to be significant contributors to the underemployment of women scientists and engineers given that pregnancy can impact research productivity (Cech and Blair-Loy, 2019 116(10)4182-4187, PNAS The Changing career trajectories of new parents in STEM ; Powell, 2021, Nature The parenting penalties faced by scientist mothers ). The demands of childbirth and subsequent primary caregiving responsibilities may necessitate changes to career goals and alter researchers career trajectories, depriving the scientific workforce of an important source of talent and undermining NIH’s investment in promising avenues of new research. Retaining investigators at this critical transition point will protect the research investment already made via the parent NIH award and enhance the diversity of the investigator pool.

Application Due Date(s) – Submission dates vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details.

NOT-OD-23-032

Expiration Date: October 01, 2025

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

To be eligible, the parent award must typically be able to receive funds at the time of the award. The administrative supplement budget request is limited to 1 year.

Supplement budget requests cannot exceed $70,000/year direct costs, and applicable F&A (indirect) cost can also be requested. Budgets may not exceed the total direct costs of the current parent award. Requests must reflect the actual needs of the proposed project. Categorical budgets are permitted. Awards are subject to availability of funds.

Flexible use of supplemental funds is highly encouraged, including but is not limited to computational services, supplies, equipment, and supported effort of additional scientific staff to sustain the PD/PI’s research during a critical life event. Supplement funds may not be used for PI salary support during the regular or extended period of the grant.

PD/PIs of the following activity codes are eligible for the program: DP1 , DP2 , DP5 , R01 , R00 , R15, R16 , R21 , R34 , R35 , RF1 , R37 and U01 .PD/PIs with more than one independent research project grant award are ineligible for this supplement.

Qualifying Critical Life Events: The PD/PI must demonstrate a critical life event during the parent grant project period, such as childbirth, adoption, serious personal health issues or illness and/or debilitating conditions, high-risk pregnancy, primary caregiving responsibilities of an ailing spouse, child, partner, parent, or a member of the immediate family. In circumstances in which the critical life event is pending and is expected to occur during the project period, the supplement period may be submitted in advance of the event. Detailed personal health information such as specific diagnoses or medical conditions is not required or necessary to be considered for this supplement.

For supplements to parent awards that include multiple PDs/PIs, the supplement may be requested by any of the PDs/PIs (in accordance with the existing leadership plan and on behalf of the PD/PI who meets the eligibility criteria) and submitted by the grantee institution of the parent award. It should be noted that for the parent grant and for the administrative supplement, the grantee is the institution, not the PD/PI.

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity